(Q30729591)

26 June 2017

title

Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation (English)

1 reference

26 June 2017

0 references

1 reference

Anders Asberg

1

0 references

Alan Jardine

object named as

Alan G Jardine

3

0 references

author name string

Hallvard Holdaas

2

1 reference

26 June 2017

Cecilie Edvardsen

4

1 reference

26 June 2017

Anders Hartmann

5

1 reference

26 June 2017

publication date

1 August 2003

1 reference

26 June 2017

published in

Clinical Transplantation

1 reference

26 June 2017

volume

17

1 reference

26 June 2017

issue

4

1 reference

26 June 2017

page(s)

385-390

1 reference

Long-term survival in renal transplant recipients with graft function

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Nonspecific microvascular vasodilation during iontophoresis is attenuated by application of hyperosmolar saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Each administration of cyclosporin A enhances skin microvascular reactivity in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Relationship of diastolic blood pressure with cyclic GMP excretion among young adults (the CARDIA Study): influence of a family history of hypertension. Coronary Artery Risk Development in Young Adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Superoxide anion scavenging properties of fluvastatin and its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

An in vitro study of the hydroxyl radical scavenging property of fluvastatin, and HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

Atorvastatin improves endothelial function in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

A Simple Method for the Determination of Glomerular Filtration Rate

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

Optimum time of blood sampling for determination of glomerular filtration rate by single-injection [51Cr]EDTA plasma clearance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2003.00063.X

7 January 2021

10.1034/J.1399-0012.2003.00063.X

Identifiers

DOI

1 reference

26 June 2017

1 reference